Is Massachusetts a volume pharmaceutical manufacturing state?
It is more often a specialty, sterile, and research-adjacent market. Confirm commercial batch capability if volume is the buying criterion.
When a Massachusetts pharmaceutical site is the right plant
Massachusetts pharmaceutical manufacturing is a specialty, sterile, and research-adjacent market. Buyers usually come for capability and quality-system fit, not for lowest-cost commercial volume.
Clusters this page covers
- Boston and Cambridge research-adjacent and specialty sites
- Suburban commercial, sterile, and packaging plants
- Worcester and western Massachusetts production nodes
- Logan air-cargo access for clinical and high-value finished goods
Selection rules
- Match sterile, specialty, or development scope first. A Massachusetts listing is not automatically a high-volume solid-oral plant.
- Ask which operations are on site versus networked to another U.S. or overseas site.
- Require clinical-versus-commercial clarity in the RFQ.
- Use Massachusetts when the science, sterile scope, or sponsor network is already in New England.
When to use a finished-dose plant, a packager, or a development site
A pharmaceutical manufacturer can be a commercial plant, a packager, or a development lab. Choose the site type before comparing listed profiles.
| When this is the job | Use | Why |
|---|---|---|
| Commercial finished-dose supply with batch records and release testing | cGMP finished-dose manufacturer | The award depends on registered process, documentation, and inspection history. |
| Primary or secondary packaging, serialization, or labeling only | Pharmaceutical packager | The product is already made; the constraint is coding, artwork, and distribution-ready pack-out. |
| Clinical, scale-up, or formulation development before commercial transfer | Development or CDMO site | The buyer needs process development and tech-transfer evidence, not only commercial volume. |
How to source this work
Use a pharmaceutical manufacturer when cGMP, FDA registration, dosage form, contamination control, and batch documentation—not general contract manufacturing capacity—are the buying criteria.
Include in the RFQ
- dosage form, batch size, and commercial or clinical intent
- required registrations, licenses, and quality-system scope
- raw-material, packaging-component, and approved-source rules
- in-process, release, and stability testing requirements
- serialization, labeling, storage, and change-control expectations
Questions that separate suppliers
- Is the site registered and inspected for this dosage form?
- Which operations are performed in-house versus by a qualified contractor?
- What batch records, COAs, and deviation history will the buyer receive?
Questions this page can answer
Which states should be compared with Massachusetts?
North Carolina, New Jersey, Pennsylvania, and California are the usual next pages, depending on whether the program is sterile, finished-dose, or packaging-led.
How should a buyer compare pharmaceutical manufacturers?
Start with dosage form, registration, and quality-system scope. Then compare which operations are on site, what batch records look like, and whether the site is set up for clinical or commercial supply. Directory listing is not an FDA approval.
Which states should pharmaceutical buyers check first?
New Jersey, Pennsylvania, North Carolina, Massachusetts, and California are the first UNITEMFG state-and-category pages to open. Use California for specialty, clinical, and West Coast packaging work; keep the Mid-Atlantic pages for finished-dose density.
Listed Pharmaceuticals Companies in Massachusetts
Results are ordered alphabetically. Inclusion is based on the matching process or industry recorded on each published profile.
Specialties: Specialty Medical SuppliesPre-formed OrthosesFall Management EquipmentDiagnostic Accessories
Specialties: Contract DevelopmentManufacturing OrganizationBiologicsGene Therapy
Specialties: Preclinical Laboratory ServicesClinical Laboratory ServicesPharmaceutical TestingDrug Development Support
Specialties: Small Molecule DrugsInfectious Disease TreatmentsMulti-drug Resistant PathogensNucleoside Analogs
Specialties: Bio-pharma InstrumentationProcess ControlsMedical DevicesContract Manufacturing
Specialties: TGFβ Superfamily TherapeuticsProtein Growth FactorsBiopharmaceuticalsClinical-stage Therapies
Specialties: End-to-end Contract ManufacturingMedical DevicesComplex ComponentsLess-invasive Procedures
Need Help Finding Pharmaceuticals in Massachusetts?
Our directory makes it easy to research listed manufacturing companies.